Daniel Klamer, Phd, Mba

Daniel Klamer, Phd, Mba Email and Phone Number

​Vice President, Business Development​ and Scientific Strategy​ @ Anavex Life Sciences
New York, NY, US
Daniel Klamer, Phd, Mba's Location
New York, New York, United States, United States
Daniel Klamer, Phd, Mba's Contact Details

Daniel Klamer, Phd, Mba work email

Daniel Klamer, Phd, Mba personal email

About Daniel Klamer, Phd, Mba

Scientific & Commercialization Strategy / Biopharmaceutical Drug Development / New Business OpportunitiesKey expertise includes: pre-clinical, clinical, regulatory, and commercial aspects of drug development; competitive and market analysis; precision medicine; business strategy; due diligence; project and team leadership.* * * * * * * * * * * * * *Bringing science and business together, I drive promising strategies and initiatives for meaningful impact on those with debilitating neurodegenerative and neurodevelopmental disorders.As a neuroscientist with a Ph.D. in Pharmacology, my background includes years of clinical and pre-clinical research, development of preclinical hypotheses into proven concepts, and supervision of other scientists’ promising projects.As a goal-oriented business leader, I have steered key projects from discovery to development, identified new indications to target, analyzed new opportunities for acquisition and partnering, co-founded a startup, and attracted investors.With my combined experiences and skills, I:- Translate scientific ideas into viable commercialization- Break problems apart and create effective solutions- Identify promising opportunities and effectively assess the risks and benefits of potential mergers and partnerships- Build collaborative relationships with external and internal partners- Create and present realistic, executable timelines and plans for strategic projects- Align and engage teams to highest performance and productivity, and inspire them to achieve key goalsIt is a privilege to apply my skills and expertise at Anavex and contribute to new and effective biopharmaceutical treatments for diseases with a high unmet medical need.

Daniel Klamer, Phd, Mba's Current Company Details
Anavex Life Sciences

Anavex Life Sciences

View
​Vice President, Business Development​ and Scientific Strategy​
New York, NY, US
Website:
anavex.com
Employees:
45
Daniel Klamer, Phd, Mba Work Experience Details
  • Anavex Life Sciences
    ​Vice President, Business Development​ And Scientific Strategy​
    Anavex Life Sciences
    New York, Ny, Us
  • Anavex Life Sciences
    ​Vice President, Business Development​ & Scientific Strategy​
    Anavex Life Sciences Jun 2017 - Present
    New York City, Ny, Us
    Craft the strategic business case (scientific and commercial) for new drug development initiatives, guide the multi-stage commercialization process and lead the sourcing and assessment of new market opportunities, possible acquisitions, and partnerships. Played role in developing the company to its current position, with multiple late-stage assets with the potential to treat several neurodegenerative and neurodevelopmental diseases. A key member of the Management Team.• Repeatedly spearhead process to identify potential diseases and target populations, conduct competitive and market analysis, and guide drug development from pre-clinical proof of concept to commercialization• Assess new, competitive, and potentially synergistic therapeutic compounds or devices• Developed a structured, efficient process and lead detailed due diligence on potential deals• Present at investor and scientific conferences
  • Anavex Life Sciences
    Senior Director Of Business Development
    Anavex Life Sciences Sep 2015 - May 2017
    New York City, Ny, Us
    Joined as 3rd employee, playing a vital role in the company’s initial growth and pipeline development
  • Department Of Pharmacology, The Sahlgrenska Academy At  University Of Gothenburg
    Associate Professor (Part-Time Since 2010)
    Department Of Pharmacology, The Sahlgrenska Academy At University Of Gothenburg Apr 2009 - Present
    Supervise multiple doctoral and master’s-level pre-clinical and clinical research projects• Developing preclinical hypotheses to clinical proof-of-concept studies• Lead international seminars and successfully obtained major research funding grants
  • Cognite Ab
    Co-Founder
    Cognite Ab Mar 2010 - Dec 2022
    • Hired and built effective, cross-functional team of experts in business development and marketing, intellectual property law and operations• Attracted critical new investors and partners• Negotiated major investment to commercialize Eidisine™ including significant financing by venture capital
  • Retrophin
    Business Development Analyst
    Retrophin Apr 2014 - Feb 2015
    Played central role in identifying strategic buying and partnering opportunities within a tight timeframe• Created product and company financial models and scenario assessments, and performed due diligence• Contributed to deal negotiations and execution• Identified and evaluated companies/products for orphan indications in e.g. liver, kidney and CNS• Analyzed the competitive drug landscape from both financial and scientific perspective
  • Intellect Neurosciences, Inc.
    Senior Scientist & Project Leader
    Intellect Neurosciences, Inc. Jan 2013 - Apr 2013
    Led development of product pipeline and out-licensing. Developed, managed and communicated integrated project plans to partners and CROs.
  • Neurosearch
    Senior Research Scientist
    Neurosearch Jun 2010 - Dec 2011
    Led and evaluated multiple discovery-phase neuropharmacological research products with a focus on strategic evaluation at preclinical and clinical stages for development and commercialization. Managed teams of up to 15 people, from technicians to Ph.D. level. Led key projects for transitioning discovery phase substances into candidate drugs; crafted and sold business case and obtained critical financing for development.
  • Department Of Pharmacology, The Sahlgrenska Academy At University Of Gothenburg
    Post-Doc/Senior Researcher
    Department Of Pharmacology, The Sahlgrenska Academy At University Of Gothenburg Jan 2007 - Mar 2009
    Gothenburg, Se
    Investigated cognitive impairments in psychiatric diseases.
  • Department Of Psychiatry, Yale University School Of Medicine
    Post-Doc
    Department Of Psychiatry, Yale University School Of Medicine Aug 2005 - Dec 2006
    Investigated neuronal synchronization in order to identify cognitive processes.Participated in the course “Learning to mentor a new generation of scientists” and workshops for “Preparing future science faculty”.
  • Department Of Pharmacology, The Sahlgrenska Academy At University Of Gothenburg
    Research Position
    Department Of Pharmacology, The Sahlgrenska Academy At University Of Gothenburg Jan 2005 - Aug 2005

Daniel Klamer, Phd, Mba Skills

Neuroscience Pharmacology Biotechnology Clinical Development Drug Discovery Biochemistry Research R&d Lifesciences Pharmaceutical Industry Clinical Trials Start Ups Project Management Drug Development Team Leadership Molecular Biology Scientific Writing Animal Models Strategic Planning Team Building Business Strategy Business Development Neurology Science Commercialization Financial Modeling Project Planning Cell Biology Company Valuation Due Diligence Product Development Entrepreneurship Cro Cell Financial Analysis Clinical Research Laboratory Healthcare Genetics Translational Medicine Organic Chemistry Mergers And Acquisitions Presentations Strategy Venture Capital Workforce Planning Management Customer Relations Competitive Analysis Strategic Partnerships

Daniel Klamer, Phd, Mba Education Details

  • Fordham Gabelli School Of Business
    Fordham Gabelli School Of Business
    Finance
  • University Of Gothenburg
    University Of Gothenburg
    Pharmacology
  • Uc San Diego
    Uc San Diego
    Department Of Psychiatry

Frequently Asked Questions about Daniel Klamer, Phd, Mba

What company does Daniel Klamer, Phd, Mba work for?

Daniel Klamer, Phd, Mba works for Anavex Life Sciences

What is Daniel Klamer, Phd, Mba's role at the current company?

Daniel Klamer, Phd, Mba's current role is ​Vice President, Business Development​ and Scientific Strategy​.

What is Daniel Klamer, Phd, Mba's email address?

Daniel Klamer, Phd, Mba's email address is da****@****ail.com

What schools did Daniel Klamer, Phd, Mba attend?

Daniel Klamer, Phd, Mba attended Fordham Gabelli School Of Business, University Of Gothenburg, Uc San Diego.

What are some of Daniel Klamer, Phd, Mba's interests?

Daniel Klamer, Phd, Mba has interest in Martial Arts, Skiing, Interest In Running.

What skills is Daniel Klamer, Phd, Mba known for?

Daniel Klamer, Phd, Mba has skills like Neuroscience, Pharmacology, Biotechnology, Clinical Development, Drug Discovery, Biochemistry, Research, R&d, Lifesciences, Pharmaceutical Industry, Clinical Trials, Start Ups.

Who are Daniel Klamer, Phd, Mba's colleagues?

Daniel Klamer, Phd, Mba's colleagues are Janusz Debowski, James T., Andrew Morris, Alessandro Mammoli, Vanessa Vogel-Farley, Fernando Caday, Clara Silvey.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.